Home Cart Sign in  
Chemical Structure| 116666-63-8 Chemical Structure| 116666-63-8

Structure of Mibefradil 2HCl
CAS No.: 116666-63-8

Chemical Structure| 116666-63-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Mibefradil 2HCl is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying

Synonyms: Ro 40-5967 dihydrochloride; Mibefradil (dihydrochloride); Posicor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mibefradil 2HCl

CAS No. :116666-63-8
Formula : C29H40Cl2FN3O3
M.W : 568.55
SMILES Code : O=C(O[C@@]1(CCN(CCCC2=NC3=CC=CC=C3N2)C)[C@@H](C(C)C)C4=C(C=C(F)C=C4)CC1)COC.[H]Cl.[H]Cl
Synonyms :
Ro 40-5967 dihydrochloride; Mibefradil (dihydrochloride); Posicor
MDL No. :MFCD00881804
InChI Key :MTJLQTFHJIHXIX-GDUXWEAWSA-N
Pubchem ID :60662

Safety of Mibefradil 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02024919 Coronary Artery Ectasia Not Applicable Completed - Turkey ... More >> Ankara University School Of Medicine, Department of Cardiology Ankara, Turkey, 06230 Less <<
NCT01480050 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02202993 Glioblastoma Multiforme (GBM) Phase 1 Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06520 Less <<
NCT01550458 Healthy Phase 1 Completed - United States, Nebraska ... More >> Celerion, Inc. Lincoln, Nebraska, United States, 68502 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.79mL

1.76mL

0.88mL

17.59mL

3.52mL

1.76mL

References

 

Historical Records

Categories